메뉴 건너뛰기




Volumn 4, Issue 1, 2016, Pages 9-18

A quantitative key-opinion-leader analysis of innovation barriers in probiotic research and development: Valorisation and improving the tech transfer cycle

Author keywords

Barriers; Innovation; Probiotics

Indexed keywords

PROBIOTIC AGENT;

EID: 84950132033     PISSN: None     EISSN: 22134344     Source Type: Journal    
DOI: 10.1016/j.phanu.2015.09.003     Document Type: Article
Times cited : (54)

References (38)
  • 1
    • 84905675648 scopus 로고    scopus 로고
    • Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
    • [1] Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11 (2014), 506–514, 10.1038/nrgastro.2014.66.
    • (2014) Nat. Rev. Gastroenterol. Hepatol. , vol.11 , pp. 506-514
    • Hill, C.1    Guarner, F.2    Reid, G.3    Gibson, G.R.4    Merenstein, D.J.5    Pot, B.6
  • 2
    • 84875348375 scopus 로고    scopus 로고
    • Actual concept of probiotics: is it more functional to science or business?
    • [2] Caselli, M., Cassol, F., Calò, G., Holton, J., Zuliani, G., Gasbarrini, A., Actual concept of probiotics: is it more functional to science or business?. WJG 19 (2013), 1527–1540, 10.3748/wjg.v19.i10.1527.
    • (2013) WJG , vol.19 , pp. 1527-1540
    • Caselli, M.1    Cassol, F.2    Calò, G.3    Holton, J.4    Zuliani, G.5    Gasbarrini, A.6
  • 3
    • 84881547933 scopus 로고    scopus 로고
    • Probiotics from research to market: the possibilities, risks and challenges
    • [3] Foligné, B., Daniel, C., Pot, B., Probiotics from research to market: the possibilities, risks and challenges. Curr. Opin. Microbiol. 16 (2013), 284–292, 10.1016/j.mib.2013.06.008.
    • (2013) Curr. Opin. Microbiol. , vol.16 , pp. 284-292
    • Foligné, B.1    Daniel, C.2    Pot, B.3
  • 4
    • 84875863443 scopus 로고    scopus 로고
    • An update on the use and investigation of probiotics in health and disease
    • [4] Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M., Sartor, R.B., et al. An update on the use and investigation of probiotics in health and disease. Gut 62 (2013), 787–796, 10.1136/gutjnl-2012-302504.
    • (2013) Gut , vol.62 , pp. 787-796
    • Sanders, M.E.1    Guarner, F.2    Guerrant, R.3    Holt, P.R.4    Quigley, E.M.5    Sartor, R.B.6
  • 5
    • 84908170025 scopus 로고    scopus 로고
    • Recommendations for probiotic use in humansaupdate
    • [5] Floch, M.H., Recommendations for probiotic use in humansaupdate. Pharmaceuticals 7 (2014), 999–1007, 10.3390/ph7100999.
    • (2014) Pharmaceuticals , vol.7 , pp. 999-1007
    • Floch, M.H.1
  • 6
    • 7744222428 scopus 로고    scopus 로고
    • Health care organizations as complex adaptive systems
    • S.S.F. Mick P.D. Shay Jossey-Bass San Francisco
    • [6] Begun, J.W., Zimmerman, B., Dooley, K., Health care organizations as complex adaptive systems. Mick, S.S.F., Shay, P.D., (eds.) Advances in Health Care Organization Theory, 2003, Jossey-Bass, San Francisco.
    • (2003) Advances in Health Care Organization Theory
    • Begun, J.W.1    Zimmerman, B.2    Dooley, K.3
  • 8
    • 31144438108 scopus 로고    scopus 로고
    • Innovation in healthcare: a systematic review of recent research
    • [8] Länsisalmi, H., Kivimäki, M., Aalto, P., Ruoranen, R., Innovation in healthcare: a systematic review of recent research. Nurs. Sci. Q. 19 (2006), 66–72, 10.1177/0894318405284129.
    • (2006) Nurs. Sci. Q. , vol.19 , pp. 66-72
    • Länsisalmi, H.1    Kivimäki, M.2    Aalto, P.3    Ruoranen, R.4
  • 9
    • 80054102456 scopus 로고    scopus 로고
    • Probiotics for prevention and treatment of diarrhea
    • [9] Guandalini, S., Probiotics for prevention and treatment of diarrhea. J. Clin. Gastroenterol. 45 (2011), S149–S153, 10.1097/MCG.0b013e3182257e98.
    • (2011) J. Clin. Gastroenterol. , vol.45 , pp. S149-S153
    • Guandalini, S.1
  • 10
    • 84923844582 scopus 로고    scopus 로고
    • Probiotics for prevention of necrotizing enterocolitis in preterm infants
    • [10] AlFaleh, K., Anabrees, J., Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid. Based Child Health 9 (2014), 584–671, 10.1002/ebch.1976.
    • (2014) Evid. Based Child Health , vol.9 , pp. 584-671
    • AlFaleh, K.1    Anabrees, J.2
  • 12
    • 84928724733 scopus 로고    scopus 로고
    • A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union
    • [12] Glanville, J., King, S., Guarner, F., Hill, C., Sanders, M.E., A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union. Nutr. J., 14, 2015, 16, 10.1186/s12937-015-0004-5.
    • (2015) Nutr. J. , vol.14 , pp. 16
    • Glanville, J.1    King, S.2    Guarner, F.3    Hill, C.4    Sanders, M.E.5
  • 13
    • 84879601489 scopus 로고    scopus 로고
    • Barriers to innovation in the medical nutrition industry: a quantitative key opinion leader analysis
    • [13] Weenen, T.C., Pronker, E.S., Commandeur, H.R., Claassen, E.H.J.M., Barriers to innovation in the medical nutrition industry: a quantitative key opinion leader analysis. PharmaNutrition 1 (2013), 79–85, 10.1016/j.phanu.2013.04.001.
    • (2013) PharmaNutrition , vol.1 , pp. 79-85
    • Weenen, T.C.1    Pronker, E.S.2    Commandeur, H.R.3    Claassen, E.H.J.M.4
  • 14
    • 0032669294 scopus 로고    scopus 로고
    • Barriers to innovation for SMEs in a small less developed country (Cyprus)
    • [14] Hadjimanolis, A., Barriers to innovation for SMEs in a small less developed country (Cyprus). Technovation 570 (1999), 34–36, 10.1016/S0166-4972(99)00034-6.
    • (1999) Technovation , vol.570 , pp. 34-36
    • Hadjimanolis, A.1
  • 15
    • 84930381579 scopus 로고    scopus 로고
    • Adopting Health Apps, What's Hindering Doctors and Patients?
    • [15] Dehzad, F., Hilhorst, C., de Bie, C., Claassen, E., Adopting Health Apps, What's Hindering Doctors and Patients?. Health 6 (2014), 2204–2217, 10.4236/health.2014.616256.
    • (2014) Health , vol.6 , pp. 2204-2217
    • Dehzad, F.1    Hilhorst, C.2    de Bie, C.3    Claassen, E.4
  • 16
    • 84943154656 scopus 로고    scopus 로고
    • Innovation paradox in vaccine target selection
    • Erasmus University Rotterdam Rotterdam, The Netherlands Retrieved from:.
    • [16] Pronker, E.S., Innovation paradox in vaccine target selection. Doctoral Thesis, 2013, Erasmus University Rotterdam, Rotterdam, The Netherlands Retrieved from: http://hdl.handle.net/1765/1.
    • (2013) Doctoral Thesis
    • Pronker, E.S.1
  • 17
    • 84982214434 scopus 로고    scopus 로고
    • Valorisation at the EUR. In P.A.G. van Bergeijk & L. Johnson (eds), Social impact @ sciences: The end of the ivory tower? (pp.). Retrieved from:.
    • [17] Claassen E. Valorisation at the EUR. In P.A.G. van Bergeijk & L. Johnson (eds), Social impact @ sciences: The end of the ivory tower? (pp. 30–39). Retrieved from: http://www.iss.nl/fileadmin/ASSETS/iss/Documents/Academic_publications/Social_impact_sciences_conference_book_Oct2014.pdf.
    • Claassen, E.1
  • 19
    • 60549089819 scopus 로고    scopus 로고
    • Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance
    • [19] Van Baarlen, P., Troost, F.J., van Hemert, S., van der Meer, C., de Vos, W.M., de Groot, P.J., et al. Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. PNAS 106 (2009), 2371–2376, 10.1073/pnas.0809919106.
    • (2009) PNAS , vol.106 , pp. 2371-2376
    • Van Baarlen, P.1    Troost, F.J.2    van Hemert, S.3    van der Meer, C.4    de Vos, W.M.5    de Groot, P.J.6
  • 20
    • 40049085247 scopus 로고    scopus 로고
    • Probiotic foods and drugs: impact of US regulatory status on design of clinical trials
    • [20] Hibberd, P.L., Davidson, L., Probiotic foods and drugs: impact of US regulatory status on design of clinical trials. Clin. Infect. Dis. 46 (2008), S137–S140, 10.1086/523321.
    • (2008) Clin. Infect. Dis. , vol.46 , pp. S137-S140
    • Hibberd, P.L.1    Davidson, L.2
  • 21
    • 84866938865 scopus 로고    scopus 로고
    • Why the European Food Safety Authority was right to reject health claims for probiotics
    • [21] Katan, M.B., Why the European Food Safety Authority was right to reject health claims for probiotics. Benef. Microbes 3 (2012), 85–89.
    • (2012) Benef. Microbes , vol.3 , pp. 85-89
    • Katan, M.B.1
  • 23
    • 84866146940 scopus 로고    scopus 로고
    • Diversity, stability and resilience of the human gut microbiota
    • [23] Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230, 10.1038/nature11550.
    • (2012) Nature , vol.489 , pp. 220-230
    • Lozupone, C.A.1    Stombaugh, J.I.2    Gordon, J.I.3    Jansson, J.K.4    Knight, R.5
  • 25
    • 84856257307 scopus 로고    scopus 로고
    • Scientific substantiation of health claims in the EU
    • [25] Flynn, A., Scientific substantiation of health claims in the EU. PNAS 71 (2012), 120–126, 10.1017/s0029665111003168.
    • (2012) PNAS , vol.71 , pp. 120-126
    • Flynn, A.1
  • 26
    • 84923351295 scopus 로고    scopus 로고
    • Regulatory categories of probiotics across the globe: a review representing existing and recommended categorization
    • [26] Arora, M., Baldi, A., Regulatory categories of probiotics across the globe: a review representing existing and recommended categorization. Indian J. Med. Microbiol. 33 (2015), 2–10, 10.4103/0255-0857.150868.
    • (2015) Indian J. Med. Microbiol. , vol.33 , pp. 2-10
    • Arora, M.1    Baldi, A.2
  • 27
    • 84878146489 scopus 로고    scopus 로고
    • Lactobacillus plantarum passage through an oro-gastro-intestinal tract simulator: carrier matrix effect and transcriptional analysis of genes associated to stress and probiosis
    • [27] Bove, P., Russo, P., Capozzi, V., Gallone, A., Spano, G., Fiocco, D., Lactobacillus plantarum passage through an oro-gastro-intestinal tract simulator: carrier matrix effect and transcriptional analysis of genes associated to stress and probiosis. Microbiol. Res. 168 (2013), 351–359, 10.1016/j.micres.2013.01.004.
    • (2013) Microbiol. Res. , vol.168 , pp. 351-359
    • Bove, P.1    Russo, P.2    Capozzi, V.3    Gallone, A.4    Spano, G.5    Fiocco, D.6
  • 28
    • 84857060451 scopus 로고    scopus 로고
    • Legal status of microbial food cultures in the European Union: an overview
    • [28] Herody, C., Soyeux, Y., Hansen, E.B., Gillies, K., Legal status of microbial food cultures in the European Union: an overview. EFFL, 258, 2010.
    • (2010) EFFL , vol.258
    • Herody, C.1    Soyeux, Y.2    Hansen, E.B.3    Gillies, K.4
  • 29
    • 17044368826 scopus 로고    scopus 로고
    • The primacy of self-regulation in health promotion
    • [29] Bandura, A., The primacy of self-regulation in health promotion. Appl. Psychol. 54 (2005), 245–254, 10.1111/j.1464-0597.2005.00208.x.
    • (2005) Appl. Psychol. , vol.54 , pp. 245-254
    • Bandura, A.1
  • 30
    • 25444531717 scopus 로고    scopus 로고
    • Viability of bifidobacteria in commercial yogurt products in North Carolina
    • [30] Carr, J.P., Ibrahim, S.A., Viability of bifidobacteria in commercial yogurt products in North Carolina. Milchwissenschaft 60 (2005), 414–416.
    • (2005) Milchwissenschaft , vol.60 , pp. 414-416
    • Carr, J.P.1    Ibrahim, S.A.2
  • 31
    • 84875024576 scopus 로고    scopus 로고
    • Failures in Functional Foods: 10 Key Case Studies & 10 Key Lessons
    • New Nutrition Business London, UK
    • [31] Mellentin, J., Failures in Functional Foods: 10 Key Case Studies & 10 Key Lessons. 2007, New Nutrition Business, London, UK.
    • (2007)
    • Mellentin, J.1
  • 32
    • 84920969881 scopus 로고    scopus 로고
    • The administration of probiotics and synbiotics in immune compromised adults: is it safe?
    • [32] Van den Nieuwboer, M., Brummer, R.J., Guarner, F., Morelli, L., Cabana, M., Claassen, E., The administration of probiotics and synbiotics in immune compromised adults: is it safe?. Benef. Microbes 6 (2014), 3–17, 10.3920/BM2014.0079.
    • (2014) Benef. Microbes , vol.6 , pp. 3-17
    • Van den Nieuwboer, M.1    Brummer, R.J.2    Guarner, F.3    Morelli, L.4    Cabana, M.5    Claassen, E.6
  • 34
    • 84937519639 scopus 로고    scopus 로고
    • Probiotics for weight loss: a systematic review and meta-analysis
    • [34] Park, S., Bae, J.H., Probiotics for weight loss: a systematic review and meta-analysis. Nutr. Res. 35 (2015), 566–575, 10.1016/j.nutres.2015.05.008.
    • (2015) Nutr. Res. , vol.35 , pp. 566-575
    • Park, S.1    Bae, J.H.2
  • 35
    • 85055343018 scopus 로고    scopus 로고
    • Scientific opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    • [35] EFSA Panel on Dietetic Products, Nutrition and Allergies NDA, Scientific opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J., 8, 2010, 1763.
    • (2010) EFSA J. , vol.8 , pp. 1763
    • EFSA Panel on Dietetic Products1    Nutrition and Allergies NDA2
  • 36
    • 84982193193 scopus 로고    scopus 로고
    • Health Canada, Probiotics. Retrieved from:.
    • [36] Health Canada, Probiotics, (2012). Retrieved from: http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=probio&lang=eng.
    • (2012)
  • 37
    • 84886717096 scopus 로고    scopus 로고
    • Probiotics and prebiotics: health claim substantiation
    • [37] Salminen, S., Van Loveren, H., Probiotics and prebiotics: health claim substantiation. Microb. Ecol. Health Dis., 2012, 23, 10.3402/mehd.v23i0.18568.
    • (2012) Microb. Ecol. Health Dis. , pp. 23
    • Salminen, S.1    Van Loveren, H.2
  • 38
    • 84928266303 scopus 로고    scopus 로고
    • A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe
    • [38] Miquel, S., Beaumont, M., Martín, R., Langella, P., Braesco, V., Thomas, M., A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb. Cell Fact., 14, 2015, 48, 10.1186/s12934-015-0229-1.
    • (2015) Microb. Cell Fact. , vol.14 , pp. 48
    • Miquel, S.1    Beaumont, M.2    Martín, R.3    Langella, P.4    Braesco, V.5    Thomas, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.